According to information provided by two allied officers, it has been revealed that the United States has been planning to send two Patriot missile batteries as well as 400 military personals Turkey. All this is being planned to make sure that Turkey has back up support if Syria announces missile attack.
America is not alone, which has been providing Patriot batteries to Turkey. It has been found that four other batteries will be provided to Syria, two will be from Germany and other two will from the Netherlands.
It shall be noted that all six batteries being sent by three nations will remain under control of NATO. Turkey was quite upset as it believes that it does not have strong missile support. Things got even more intense when news was revealed about activities taking place at Syria's chemical sites.
It was in last week when NATO ministers said that it has been decided by them that Patriot batteries will be sent to Turkey. For now, deployment preparations are going on for surveys of potential sites. In total, 10 sites have been surveyed, majority of them are in southeastern Turkey. Final decision is still to be taken.
According to a Seattle Times report, software giant Microsoft paid an amount of $10,000 to California-based travel agent Teri Goldstein last month, after she took the legal route against the company over its Windows 10 upgrade tactics, and won a...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Tech giant Google posted a video of a developer presentation to the Google Developers YouTube...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
In an announcement made via a blog post on Tuesday,...
UNICEF released a report on Tuesday claiming that poor...
Pink snow in the Arctic is a naturally occurring...
New Horizons of NASA is currently heading towards its...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).